deepbio

News

Deep Bio and Visiopharm Announce a Collaborative Integration of a Clinical-Grade…

Pathologists can now have access to the state-of-the-art AI prostate cancer grading solution                                      SEOUL, SOUTH KOREA (…

November 15, 2022

News

Deep Bio Inc. successfully integrates DeepDx® Prostate algorithm into the HALO A…

Discover how Deep Bio Inc. (딥바이오) successfully integrates their DeepDx® Prostate algorithm into the HALO AP® platform from Indica Labs. Read the excit…

October 31, 2022

News

Deep Bio Acquires ISO 27001 Certification for an Information Security Management…

Enhanced security and reliability through adherence to globally recognized information security standards                                      SEOUL, …

October 27, 2022

News

Deep Bio Selected as ‘Korea AI Startup 100’ for Two Consecutive Years

AI experts expect Deep Bio to succeed in the healthcare industry with its innovative technology                                      SEOUL, SOUTH KORE…

October 21, 2022

News

Deep Bio Welcomes New Advisors to Accelerate Its Growth in Global Market

The new advisors will focus on Deep Bio’s overseas business expansion as well as strengthening its expertise in cancer pathology.                     …

October 11, 2022

News

Deep Bio’s AI Support for Prostate Cancer Diagnosis will be Deployed at Five Kor…

DeepDx®-Prostate Pro, designated as an Innovative Product by the Korea Public Procurement Service, is expected to improve pathology workflows in real …

October 10, 2022

News

Deep Bio Acquires MDSAP Certification, Paving the Way for Global Expansion

Demonstrated globally-recognized standards in safety and quality management as a medical software manufacturer.         SEOUL, SOUTH KOREA (PRWEB) AUG…

August 16, 2022

News

Deep Bio’s AI Support for Cancer Diagnosis has been Designated as an Innovative …

This designation marks the Korean government’s recognition of innovation for DeepDx®-Prostate Pro.     SEOUL, SOUTH KOREA (PRWEB) JULY 25, 2022 - Deep…

July 25, 2022

News

Deep Bio’s AI-based Cancer Diagnostic Software Demonstrated Uropathologist-level…

Independent external validation study results of Deep Bio’s AI algorithm for prostate cancer diagnosis were published in the Modern PathologySEOUL, SO…

May 13, 2022

News

Deep Bio Presents Research Results of AI-based Cancer Diagnosis and Prognosis at…

Five abstracts in prostate and breast cancers, Deep Bio’s main research areas, are presented during the online sessions. SEOUL, SOUTH KOREA (PRWEB) AP…

April 11, 2022

News

Join Deep Bio at AACR 2022!

Join Deep Bio at AACR 2022! At this year’s AACR, Deep Bio will present both on-site and virtually!Visit us at booth #1461 to share your thoughts on th…

April 1, 2022

News

Deep Bio Presented Deep Learning-based Cancer Research at the USCAP 111th Annual…

Five researches in regards to deep learning-based cancer diagnosis and prognosis highlightedSEOUL, SOUTH KOREA (PRWEB) MARCH 23, 2022 - Deep Bio, a pi…

March 23, 2022

News

Join Deep Bio at USCAP 2022

 Join Deep Bio at USCAP 2022We are excited to finally meet you in person at USCAP 2022!Explore how Deep Bio’s AI solutions have shaped digital patholo…

March 15, 2022

News

Deep Dive into High-Level Diagnostics

AI-mediated analysis of prostate biopsies enables faster and better diagnosesHealthcare systems are struggling with a pathologist shortfall. In the US…

October 21, 2021

News

[Interview] [Innovative Startups] Deep Bio to revolutionize prostate cancer diag…

Korea has emerged as a "technology powerhouse" as the nation is seeing new innovative startups that are working on visualizing the once futuristic tec…

September 04, 2021

News

Deep Bio Announces Research Collaboration with a Major Cancer Institute

Deep Bio renews Research Collaboration Agreement with Dana-Farber Cancer Institute SEOUL, South Korea, July 22, 2021 - Deep Bio, a leading company in …

July 22, 2021

News

Deep Bio Renews Software License Agreement with Stanford Medicine

Deep Bio provides its AI-based prostate cancer detection software for research SEOUL, SOUTH KOREA (PRWEB) JULY 16, 2021 - Deep Bio, a leading company …

July 16, 2021

News

Deep Bio Collaborates with ARUP in AI Clinical Implementation Research

ARUP applies Deep Bio’s deep learning-based prostate cancer detection and classification solution for research SEOUL, SOUTH KOREA (PRWEB) JULY 16, 202…

July 16, 2021

News

Gestalt Diagnostics and Deep Bio Announce Strategic Relationship to Deliver Imag…

Spokane, WA, and Seoul, Korea (July 14, 2021) – Gestalt Diagnostics and Deep Bio today announced their strategic relationship on the development of an…

July 14, 2021

News

Deep Bio Presents its Novel Deep Learning-based Gleason Grading System in npj Di…

Deep Bio developed a novel deep learning-based prostate cancer detection model that demonstrates superb performance trained by a weakly supervised lea…

July 1, 2021

News

Embracing Pathology’s Digital Revolution with Deep Bio

Deep Bio stands at the front and center of digital transformation with DeepDx® ProstateDigital pathology is on the rise – and, with it, artificial int…

March 22, 2021

News

Deep Bio, Clinical Trial for ‘AI-powered Prostate Cancer Diagnosis’ in Korea

Seoul, South Korea- Deep Bio announced today that it had officially commenced clinical trial on ‘DeepDx-Prostate,’ a prostate biopsy AI-based diagnost…

April 11, 2019

News

Deep Bio Inc. ranks 1st in the CAMELYON17 Grand Challenge from post submitting i…

The Deep Bio research team set the record in the Camelyon Challenge 17’ currently positioning them in first place. The Camelyon17 Grand Challenge is a…

February 12, 2019

News

Deep Bio launches AI-diagnostic software on prostate cancer .."grants certificat…

Deep Bio announced today that it had released its artificial intelligence (AI) diagnostic products for the first time in the domestic press. The compa…

December 13, 2018

News

Deep Bio recieves ISO 13485

Deep Bio, an AI-powered medical service startup company, today announced that it had granted ISO 13485:2016 certification for its Quality Management S…

September 17, 2018

News

AI-driven diagnositc company, Deep Bio Inc. closes $5 Million USD in Series A

On May 28th, AI startup ‘Deep Bio’ succeeded in Series A funding from various venture capital companies in Korea. Deep Bio is a medicalAI company that…

March 2, 2018

News

Deep Bio Inc., takes on a challenge to develop software using AI

“Learning amount ↑ · Error ↓” Utilization as a clinical supporting device .. Artificial Intelligence (AI) has now made its headway into the biotech in…

September 18, 2017

News

DeepBio, 'prostate cancer' detection using AI ..closes seed rounding

Deep Bio, is a start-up company that develops artificial intelligence (AI) to diagnose prostate cancer. There are diagnostic imagining methods such as…

August 13, 2017